Trial
NCT00460759
Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Mycobacterium Tuberculosis
Intervention
Moxifloxacin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-07